Clinical Interventions in Aging · 2018 · 40 citations · 18 references
Life SciencesImmunologyNeurologyImmunopathologyInflammationNeuroimmunologyCerebrovascular DiseaseEndothelial DysfunctionInflammatory BiomarkersNeuroinflammationNeurovascular DysfunctionStrokeCerebrovascular InflammationDisease-specific BiomarkersEndothelial Dysfunction AssessmentInflammatory VasculopathyIntercellular Adhesion Molecule 1Neurovascular InflammationStroke Severity ScoringSystemic Inflammation Markers
Background: Endothelial dysfunction (ED) is involved in the pathogenesis of cerebral small vessel disease (SVD), however, it is not clear if specific biomarkers related to ED are associated with radiological progression of SVD. Methods: A single-center, prospective cohort study was conducted among consecutive, adult patients with SVD. Logistic regression was used to analyze the association of each baseline biomarker (highest vs lowest tertile) and the MRI radiological outcome after 2 years. The mean Z-score for vascular inflammation (VI) combined soluble intercellular cell adhesion molecule-1 (sICAM-1), soluble platelet selectin (sP-selectin), CD40 ligand (sCD40 L), platelet factor-4 (PF-4) and homocysteine; Z -score for systemic inflammation (SI) combined high-sensitivity C-reactive protein (hsCRP), interleukin-1α and -6 (IL-1α and IL-6, respectively) and tumor necrosis factor-α (TNF-α). Results: The study group comprised 123 patients (age, mean±SD: 72.2±8 years, 49% females), with lacunar stroke (n=49), vascular dementia (n=48), and vascular parkinsonism (n=26). Moreover, 34.9% patients experienced radiological progression, 43% had progression of isolated white matter lesions (WMLs), 23.2% had new lacunes, and 34.8% had both WMLs progression and new lacunes. After adjustment for confounders (age, sex, blood pressure, MRI lesions load), the PF-4 (OR; 95% CI 5.5; 1.5–21), sCD40L (4.6; 1.1–18.6), IL-6 (7.4; 1.48–37), Z -score for VI (4.5; 1.1–18.6), and, marginally, homocysteine (4.1; 0.99–17) were associated with the risk of any radiological progression; further, homocysteine (2.4; 1.4–14), Z-score for SI (2.1; 1.2–14) and, marginally, IL-6 (6.0; 0.95 -38) were related to the development of new lacunes; PF-4 (7.9; 1.6–38) and, marginally, the Z-score for VI (4.2; 0.9–19.5) were correlated with the risk of WMLs progression. Additional adjustment for clinical SVD manifestations did not significantly alter the results. Conclusion: The data supports the concept that ED modulates the radiological progression of SVD and WMLs and lacunes are associated with different inflammatory markers. Keywords: cerebral small-vessel disease, radiological progression, IL-6, PF-4, sCD40 L, homocysteine
18
Gustavo C. Román, T. K. Tatemichi, Timo Erkinjuntti et al. · Neurology · 1993 · 4.9K citations
Medicine, Neurology, Neuroscience +17
Classification and natural history of clinically identifiable subtypes of cerebral infarction
John Bamford, Peter Sandercock, Martin Dennis et al. · The Lancet · 1991 · 3.3K citations
Medicine, Neurology, Neurosurgery +16
Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden
Julie Staals, Stephen Makin, Fergus Doubal et al. · Neurology · 2014 · 1K citations · Full text
Circulating IL-6 and CRP are associated with MRI findings in the elderly
Claudia L. Satizábal, Yi‐Cheng Zhu, Bernard Mazoyer et al. · Neurology · 2012 · 302 citations